Megafine Pharma (P) Ltd.

 

PRODUCTS

QUALITY STD.

THERAPEUTIC CATEGORY

TECH. PACK

REGULATORY STATUS

US DMF EU EDMF

EU CEP

JP PDMA

CA DMF

AUS TGA

Human Use

Cinacalcet HCl

IHS

Anti-hypeparathyroidism

       

Darifenacin HBr

IHS

Overactive Bladder

       

Desvenlafaxine Succinate

IHS

Anti-depressant

       

Donepezil HCl Form I

IHS

Anti-alzheimer’s

   

Donepezil HCl Form III

IHS

Anti-alzheimer’s

         
Memantine HCl IHS Anti-alzheimer’s            

Mirtazapine Anhydrous

USP / EP / IP

Anti-depressant

       

Mirtazapine Hemihydrate

USP / EP / IP

Anti-depressant

 

Quetiapine Hemifumarate

IHS / IP

Anti-schizophrenia

       

Solifenacin Succinate

IHS

Overactive Bladder

       

Venlafaxine HCl

EP

Anti-depressant

     

Ziprasidone HCl

IHS

Anti-schizophrenia

       

Veterinary Use

Morantel Citrate

IHS

Anthelmintic

           

Morantel Tartrate

IHS

Anthelmintic

           

Oxantel Pamaote

IHS

Anthelmintic

       

Pyrantel Pamoate (Embonate)

USP / EP / IP

Anthelmintic

   

Pyrantel Tartate

B Vet

Anthelmintic

       

 

Note: "IHS" - In House Specifications  "U/C" - Under Compilation

Note: Products protected under specific patents in certain countries are not offered for sale by us in such countries.


APIs Under Development
PRODUCTS THERAPEUTIC CATEGORY
Bosentan Hydrate Pulmonary Artery Hypertension
Dronedarone Anti-arrhythmic
Paliperidone Anti-schizophrenia
Prasugrel Percutaneous Coronary Intervention
Strontium Ranelate Anti-osteoporotic